BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 320764)

  • 1. Volume limitations of plasmapheresis.
    Lundsgaard-Hansen P
    Vox Sang; 1977; 32(1):20-5. PubMed ID: 320764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor safety in plasmapheresis.
    Lundsgaard-Hansen P
    Dev Biol Stand; 1980; 48():287-95. PubMed ID: 7274560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observation of the changes of plasma proteins after long term plasmapheresis.
    Grgicević D; Pistotnik M; Pende B
    Dev Biol Stand; 1980; 48():279-86. PubMed ID: 6168506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide serum concentration decreases in donors undergoing discontinuous plasmapheresis involving a large extracorporeal blood volume.
    Karger R; Halbe M; Giffhorn-Katz S; Katz N; Kretschmer V
    Transfusion; 2007 Sep; 47(9):1717-24. PubMed ID: 17725739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
    Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
    Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Substitution of plasma proteins following individual collections of plasma in the course of long-term plasmapheresis. II].
    Smálik S; Stanislavová V; Strzínek M; Moscovic F
    Bratisl Lek Listy; 1971 Oct; 56(4):407-15. PubMed ID: 4110623
    [No Abstract]   [Full Text] [Related]  

  • 7. The Belgian plasmapheresis programme.
    Vermylen C
    Dev Biol Stand; 1980; 48():271-8. PubMed ID: 7274559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Source Plasma Donation: The Experience of the Iranian Blood Transfusion Organization.
    Mohammadi S; Aghabozorg F; Balagholi S; Ferdowsi S; Sharifi S; Eshghi P
    Int J Hematol Oncol Stem Cell Res; 2022 Jul; 16(3):151-156. PubMed ID: 36694705
    [No Abstract]   [Full Text] [Related]  

  • 9. Current plasmapheresis practice in the United States.
    Tullis JL
    Ric Clin Lab; 1983; 13(1):11-9. PubMed ID: 6344176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
    Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
    Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrophoretic control of serum proteins in donors designated for plasmapheresis. Initial evaluation of the analysis of 3500 donors].
    Fine JM; Marneux M; Sayarath V
    Rev Fr Transfus Immunohematol; 1985 May; 28(2):125-36. PubMed ID: 4023543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Canadian Red Cross plasmapheresis donor safety program: changes in plasma proteins after long-term plasmapheresis.
    Wasi S; Santowski T; Murray SA; Perrault RA; Gill P
    Vox Sang; 1991; 60(2):82-7. PubMed ID: 2031342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmapheresis-induced hemodilution and its effects on serum constituents.
    Friedman BA; Schork MA; Alm SK; Jones AS; Oberman HA
    Transfusion; 1976; 16(2):155-61. PubMed ID: 1258117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of long-term plasmapheresis on blood coagulation.
    Grgicević D
    Ric Clin Lab; 1983; 13(1):21-31. PubMed ID: 6407088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Vampire syndrome': serum protein and lipid abnormalities related to frequent sale of plasma.
    Jones DK; Dunn MI
    J Fam Pract; 1995 Mar; 40(3):288-90. PubMed ID: 7876787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term and long-term effects of plasmapheresis on serum proteins and immunoglobulins.
    Friedman BA; Schork MA; Mocniak JL; Oberman HA
    Transfusion; 1975; 15(5):467-72. PubMed ID: 53919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of plasmapheresis on IgG and albumin].
    Flesland O; Halvorsen R; Solheim BG; Orjasaeter H
    Tidsskr Nor Laegeforen; 1990 Jun; 110(15):1936-7. PubMed ID: 2363163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective trial on the safety of long-term intensive plasmapheresis in donors.
    Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P
    Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal blood volume of donors during automated intermittent-flow plasmapheresis and its relevance to the prevention of circulatory reactions.
    Karger R; Slonka J; Junck H; Kretschmer V
    Transfusion; 2003 Aug; 43(8):1096-106. PubMed ID: 12869116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanical donor plasmapheresis using the Haemonetics Ultralite plasma collection system. 1. Collection of fresh plasma].
    Matthes G; Pawlow I; Richter E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):343-8. PubMed ID: 2475417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.